Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC - Yang, James Chih-Hsin; Lu, Shun; Hayashi, Hidetoshi; Felip, Enriqueta; Spira, Alexander I.; Girard, Nicolas; Kim, Yu Jung; Lee, Se-Hoon; Ostapenko, Yurii; Danchaivijitr, Pongwut; Liu, Baogang; Alip, Adlinda; et al. (The New England journal of medicine, 2025)
Online verfügbar: 06. September 2026